Sanjeeva Srivastava

Dr. Sanjeeva Srivastava

Indian Institute of Technology, Bombay, Mumbai, India
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2011 in Proteomics
Verified
Journal Article
Closed access
PDF file
SRSandipan Ray
Sandipan Ray
PRPanga J. Reddy
Panga J. Reddy
RJRekha Jain
Rekha Jain
KGKishore Gollapalli
Kishore Gollapalli
AMAliasgar Moiyadi
Aliasgar Moiyadi
Sanjeeva SrivastavaSanjeeva Srivastava
Sanjeeva Srivastava

18 February 2010 in Proteomics
Verified
Journal Article
Closed access
PDF file
SRSandipan Ray
Sandipan Ray
GMGunjan Mehta
Gunjan Mehta
Sanjeeva SrivastavaSanjeeva Srivastava
Sanjeeva Srivastava

31 May 2020 in Journal of Proteins and Proteomics
Verified
Journal Article
Open access
PDF file
SRSandipan Ray
Sandipan Ray
Sanjeeva SrivastavaSanjeeva Srivastava
Sanjeeva Srivastava
Nowadays, e-learning and virtual labs have gained substantial popularity in science education. Amid the COVID-19 shutdowns, regular in-person classroom teaching and lab courses are suspended in several countries worldwide. In this scenario, virtual classes and online resources could serve more effectively as a possible alternative way of learning science from home.

5 April 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Vineeta RaiVineeta Rai
Vineeta Rai
MMMuthusivaramapandian Muthuraj
Muthusivaramapandian Muthuraj
MGMayuri N. Gandhi
Mayuri N. Gandhi
DDDebasish Das
Debasish Das
Sanjeeva SrivastavaSanjeeva Srivastava
Sanjeeva Srivastava
To understand the post-transcriptional molecular mechanisms attributing to oleaginousness in microalgae challenged with nitrogen starvation (N-starvation), the longitudinal proteome dynamics of Chlorella sp. FC2 IITG was investigated using multipronged quantitative proteomics and multiple reaction monitoring assays. Physiological data suggested a remarkably enhanced lipid accumulation with concomitant reduction in carbon flux towards carbohydrate, protein and chlorophyll biosynthesis. The proteomics-based investigations identified the down-regulation of enzymes involved in chlorophyll biosynthesis (porphobilinogen deaminase) and photosynthetic carbon fixation (sedoheptulose-1,7 bisphosphate and phosphoribulokinase). Profound up-regulation of hydroxyacyl-ACP dehydrogenase and enoyl-ACP reductase ascertained lipid accumulation. The carbon skeletons to be integrated into lipid precursors were regenerated by glycolysis, β-oxidation and TCA cycle. The enhanced expression of glycolysis and pentose phosphate pathway enzymes indicates heightened energy needs of FC2 cells for the sustenance of N-starvation. FC2 cells strategically reserved nitrogen by incorporating it into the TCA-cycle intermediates to form amino acids; particularly the enzymes involved in the biosynthesis of glutamate, aspartate and arginine were up-regulated. Regulation of arginine, superoxide dismutase, thioredoxin-peroxiredoxin, lipocalin, serine-hydroxymethyltransferase, cysteine synthase, and octanoyltransferase play a critical role in maintaining cellular homeostasis during N-starvation. These findings may provide a rationale for genetic engineering of microalgae, which may enable synchronized biomass and lipid synthesis.

27 April 2021 in Frontiers in Physiology
Verified
Journal Article
Open access
KSKruthi Suvarna
Kruthi Suvarna
DBDeeptarup Biswas
Deeptarup Biswas
MPMedha Gayathri J. Pai
Medha Gayathri J. Pai
AAArup Acharjee
Arup Acharjee
RBRenuka Bankar
Renuka Bankar
Sanjeeva SrivastavaSanjeeva Srivastava
Sanjeeva Srivastava
The pestilential pathogen SARS-CoV-2 has led to a seemingly ceaseless pandemic of COVID-19. The healthcare sector is under a tremendous burden, thus necessitating the prognosis of COVID-19 severity. This in-depth study of plasma proteome alteration provides insights into the host physiological response towards the infection and also reveals the potential prognostic markers of the disease. Using label-free quantitative proteomics, we performed deep plasma proteome analysis in a cohort of 71 patients (20 COVID-19 negative, 18 COVID-19 non-severe, and 33 severe) to understand the disease dynamics. Of the 1200 proteins detected in the patient plasma, 38 proteins were identified to be differentially expressed between non-severe and severe groups. The altered plasma proteome revealed significant dysregulation in the pathways related to peptidase activity, regulated exocytosis, blood coagulation, complement activation, leukocyte activation involved in immune response, and response to glucocorticoid biological processes in severe cases of SARS-CoV-2 infection. Furthermore, we employed supervised machine learning (ML) approaches using a linear support vector machine model to identify the classifiers of patients with non-severe and severe COVID-19. The model used a selected panel of 20 proteins and classified the samples based on the severity with a classification accuracy of 0.84. Putative biomarkers such as angiotensinogen and SERPING1 and ML-derived classifiers including the apolipoprotein B, SERPINA3, and fibrinogen gamma chain were validated by targeted mass spectrometry-based multiple reaction monitoring (MRM) assays. We also employed an in silico screening approach against the identified target proteins for the therapeutic management of COVID-19. We shortlisted two FDA-approved drugs, namely, selinexor and ponatinib, which showed the potential of being repurposed for COVID-19 therapeutics. Overall, this is the first most comprehensive plasma proteome investigation of COVID-19 patients from the Indian population, and provides a set of potential biomarkers for the disease severity progression and targets for therapeutic interventions.

11 December 2024 in Nature
Verified
Journal Article
Closed access
PDF file
FHFuchu He
Fuchu He
RARuedi Aebersold
Ruedi Aebersold
MBMark S. Baker
Mark S. Baker
XBXiu-Wu Bian
Xiu-Wu Bian
XBXiaochen Bo
Xiaochen Bo
ZZZemin Zhang
Zemin Zhang